Dan Mellon, PhD

Deputy Director
US FDA
Washington, District of Columbia, United States

Presentation(s):

• Seizure Liability: New Approaches to Detection (S04)

  Monday, November 18, 2024
  2:00 PM - 5:00 PM CT

• Regulatory Challenges of Seizures in Toxicology Studies: Utility of Alternative Models in Regulatory Decision Making (S04-4)

  Monday, November 18, 2024
  3:45 PM - 4:10 PM CT